Medicine

STAT Plus: Pfizer says efficacy of its Duchenne gene therapy outweighs side effects

This post originally appeared on StatNews.

Pfizer’s experimental gene therapy to treat Duchenne muscular dystrophy appeared to improve muscle function in a study of nine boys, but also resulted in serious drug reactions in three of those children, the company said Friday.

The data are being presented at a virtual session of the American Society of Gene & Cell Therapy.

Continue to STAT Plus to read the full story…

This post originally appeared on StatNews.